Prevention Of Hiv Protease Inhibitor-Induced Inflammatory Response And Er Stress By Berberine In Macrophages

guang liang,li chen,xudong wu,emily c gurley,elaine studer,xuan wang,phillip b hylemon,william m pandak,xiaokun li,luyong zhang,huiping zhou

DOI: https://doi.org/10.1096/fasebj.22.1_supplement.1037.2

2008-01-01

Abstract:Complementary and alternative medicines are becoming increasingly attractive approaches for the treatment of HIV infection and the complications associated with highly active anti‐retroviral therapy (HAART). Our previous studies suggest that HIV PI‐induced ER stress and inflammatory response in macrophages represents an important cell signaling mechanism of HIV PI‐induced dyslipdemia and atherosclerosis. Berberine (BBR), an isoquinoline alkaloid isolated from many medicinal herbs, has various beneficial effects on the cardiovascular system. The aim of the present study was to determine if BBR was able to prevent HIV PI‐induced inflammatory response, ER stress and lipid accumulation in macrophages. J774A.1 cells and primary mouse peritoneal macrophages were used in this study. Cells were pre‐treated with BBR for 4h, and then treated with individual HIV PI. The mRNA and protein levels of TNF‐á and IL‐6 were measured by real‐time RT‐PCR and ELISA, respectively. Activation of ER stress was detected by Western blot. Intracellular free cholesterol and lipid were detected using filipin and oil‐red O staining. Results: BBR significantly inhibited HIV PI‐induced TNF‐á and IL‐6 expression and ER stress response. HIV PI‐induced free cholesterol and lipid accumulation was also markedly inhibited by BBR. Conclusions: BBR has a potential therapeutic effect on HIV PI‐induced dyslipdemia and atherosclerosis.